For research use only. Not for therapeutic Use.
CLR-1502(Cat No.:I025006)is a novel small molecule being investigated for its potential use in cancer imaging and therapy. It is a fluorescent compound that can selectively target tumors and is designed for use in fluorescence-guided surgery. CLR-1502 binds to specific cancer cells, allowing surgeons to distinguish tumor tissue from healthy tissue more clearly during surgery. Additionally, it is being explored for its potential as a theranostic agent, which combines diagnostic and therapeutic properties. Ongoing studies aim to assess its effectiveness in improving cancer detection and surgical outcomes, particularly for solid tumors.
Catalog Number | I025006 |
CAS Number | 1255922-30-5 |
Synonyms | CLR-1502; CLR 1502; CLR1502; GLOW2 |
Molecular Formula | C61H89ClN3O4P |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | 2-(trimethylazaniumyl)ethyl 18-[4-[(6E)-2-[(E)-2-(1,3,3-trimethylindol-1-ium-2-yl)ethenyl]-6-[(2E)-2-(1,3,3-trimethylindol-2-ylidene)ethylidene]cyclohexen-1-yl]phenyl]octadecyl phosphate;chloride |
InChI | InChI=1S/C61H89N3O4P.ClH/c1-60(2)53-34-25-27-36-55(53)62(5)57(60)44-42-50-32-30-33-51(43-45-58-61(3,4)54-35-26-28-37-56(54)63(58)6)59(50)52-40-38-49(39-41-52)31-24-22-20-18-16-14-12-10-11-13-15-17-19-21-23-29-47-67-69(65,66)68-48-46-64(7,8)9;/h25-28,34-45H,10-24,29-33,46-48H2,1-9H3;1H/q+1;/p-1 |
InChIKey | ABHSKOMCZVVTMW-UHFFFAOYSA-M |
SMILES | CC1(C2=CC=CC=C2[N+](=C1/C=C/C3=C(/C(=C/C=C/4\C(C5=CC=CC=C5N4C)(C)C)/CCC3)C6=CC=C(C=C6)CCCCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C)C)C.[Cl-] |